Abbott

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Abbott sits in the top decile of US sponsors by registered trial count (#166 of 15,742 sponsors by registered trial count).

181 total trials none currently recruiting 158 completed top decile by trial count

Abbott: 181 sponsored US clinical trials, none currently recruiting.

Abbott sponsors 181 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 158 completed. 90 of these trials are in Phase 3-4 (later-stage) and 83 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 7 trials.

Top-decile sponsor footprint

Abbott ranks in the top decile of sponsors by registered trial count (#166 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 58/100

158 of 181 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

181 total, page 3 of 4

COMPLETED Phase 4

Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

NCT00234897

COMPLETED Phase 3

Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis

NCT00091975

COMPLETED Phase 3

A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.

NCT00195754

COMPLETED Phase 3

Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents

NCT00195767

COMPLETED Phase 4

Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension

NCT00235001

COMPLETED Phase 4

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

NCT00234988

COMPLETED Phase 3

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00195676

COMPLETED Phase 3

Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis

NCT00085644

COMPLETED Phase 2

A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

NCT00075231

COMPLETED Phase 4

A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media

NCT00645112

COMPLETED Phase 4

Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis

NCT00645073

COMPLETED Phase 2

A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetaminophen (Vicodin® CR) and Placebo in Subjects With Pain Following Bunionectomy Surgery

NCT00404391

COMPLETED Phase 2

A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer

NCT00073151

COMPLETED Phase 2

A Study of ABT-751 in Patients With Colorectal Cancer

NCT00073138

COMPLETED Phase 3

Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis

NCT00195689

COMPLETED Phase 2

A Study of ABT-751 in Patients With Renal Cell Cancer

NCT00073112

COMPLETED Phase 3

Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

NCT00077779

COMPLETED Phase 2

Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia

NCT00073164

TERMINATED Phase 4

Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness

NCT00071253

TERMINATED Phase 3

A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children

NCT00067431

TERMINATED Phase 2

A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease

NCT00069849

COMPLETED Phase 3

The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents

NCT00195741

COMPLETED Phase 2

Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

NCT00073125

COMPLETED Phase 3

Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial Sinusitis

NCT00644553

COMPLETED Phase 2

Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00061659

COMPLETED Phase 2

Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

NCT00061672

TERMINATED Phase 4

Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

NCT00062699

COMPLETED Phase 3

Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure.

NCT00348504

COMPLETED Phase 3

An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents

NCT00067262

COMPLETED Phase 3

Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis

NCT00234845

COMPLETED NA

Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer

NCT00056654

TERMINATED Phase 2

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

NCT00061646

COMPLETED Phase 4

A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media

NCT00644943

COMPLETED Phase 2

Pediatric Switch Study for Children and Adolescent Patients With Epilepsy

NCT00646711

COMPLETED Phase 4

A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications

NCT00644774

COMPLETED Phase 3

An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder

NCT00060905

COMPLETED Phase 4

Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension Medications

NCT00644891

COMPLETED Phase 4

A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amoxicillin Antibiotic Suspension Medications

NCT00645125

COMPLETED Phase 3

A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients

NCT00234832

COMPLETED Phase 3

Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis

NCT00645086

COMPLETED Phase 2

A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

NCT00063102

COMPLETED Phase 3

Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid Arthritis

NCT00049751

COMPLETED Phase 3

Atrasentan in Treating Patients With Prostate Cancer

NCT00046943

COMPLETED Phase 3

Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)

NCT00048542

COMPLETED Phase 3

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

NCT00048425

COMPLETED Phase 3

Remission in Subjects With Crohn's Disease, 1 Year Phase

NCT00055497

COMPLETED Phase 2

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

NCT00043953

COMPLETED Phase 3

Remission in Subjects With Crohn's Disease, Open Label Extension

NCT01070303

TERMINATED Phase 4

Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

NCT00234962

COMPLETED Phase 2

Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media

NCT00645203

← Previous Page 3 of 4 Next →

How the Abbott archive is shaped

181 indexed studies, none listed as recruiting (0% open); 158 completed (87%).

Phase mix: 90 late (III/IV) vs 83 early (I/II) (balanced across stages).

Top condition: Healthy (7 trials), 9 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Abbott: archived-pipeline peers nationwide

Peers matched on 181 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Abbott sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200 0%5%10%15%20% Total trials Recruiting share AbbottViiV HealthcareBaylor Research InstituteFox Chase Cancer CenterChildren's Mercy Hospital Kansas City10xBio22nd Century Group23andMe3-C Institute for Social Development
Abbott sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Abbott sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 181 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Abbott page

181 registered trials is a research-attention snapshot, not an endorsement of Abbott or any single study.

  • None of Abbott's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Healthy is the condition Abbott studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Abbott pipeline card: 181 registered trials from official public datasets.Report a data error.